Insights

Los Angeles – June 10, 2026: Steven Chiu, an experienced and versatile health care regulatory attorney with more than 16 years of experience advising leading health care clients, has joined Crowell & Moring as a partner in Los Angeles, further strengthening the firm's fast-growing and industry-leading Health Care Group.

Washington – June 4, 2026: Crowell & Moring earned 92 individual rankings for 81 attorneys, as well as 48 national and statewide practice area rankings, in the Chambers USA 2026 guide. The Chambers guide ranks the country’s top law firms and lawyers through in-depth research, client interviews, and feedback from attorneys at peer firms. 

On Wednesday, June 3, 2026, the Department of Health and Human Services (HHS) published an interim final rule with comment (IFC) instructing all state Medicaid agencies to incorporate “community engagement” as an eligibility condition for program participation by no later than January 1, 2027. The rule (Medicaid Program; Community Engagement Requirement for Certain Individuals) does not impose affirmative operational obligations for Medicaid managed care plans, as it focuses primarily on equipping the states to administer the community engagement requirement. However, it does establish a few specific guardrails to govern the role managed care organizations, prepaid inpatient health plans, and prepaid ambulatory health plans may — and may not — play in that administration.

With the Centers for Medicare & Medicaid Services (CMS) poised to determine which organ procurement organizations (OPO) will retain their Medicare certification and service territories under a controversial new performance framework, a coalition of OPOs is fighting to have its day in court — but first, it must convince a federal judge that the courthouse doors are open to it at all. The U.S. District Court for the Middle District of Florida is actively weighing whether it has jurisdiction to hear a pre-enforcement challenge to a 2020 Final Rule, which introduced a competitive three-tier performance model that threatens lower-performing OPOs with the loss of their designated service areas (DSA) and, potentially, their Medicare certifications. The resolution of this threshold question will determine whether the plaintiff OPOs can seek judicial relief ahead of decertification proceedings, which CMS has signaled will occur after it finalizes its 2026 Proposed Rule at the end of the year.

On May 27, 2026, the U.S. District Court for the Southern District of Georgia issued a sweeping decision in Clover Insurance Company v. HHS that could ultimately lead to the invalidation of nearly half of all Star Ratings measures and, potentially, lead the Centers for Medicare & Medicaid Services (CMS) to seek statutory changes to Medicare law.

Join us for an interactive and educational event tailored for biotech leaders seeking to ensure security compliance while leveraging the power of Amazon Web Services (AWS). This session will dive into the critical elements of designing secure, scalable, and compliant systems for biotech operations, from research and development to clinical trials and beyond.

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:

This podcast episode features the following speakers:

Click below to listen or access from one of these links: PodBean | SoundCloud | iTunes

In this episode, hosts Payal Nanavati and Megan Beaver speak with Linda Malek and Matthew F. Ferraro about the latest federal and state developments in artificial intelligence (AI) policy affecting health care. The conversation covers the Trump administration’s AI action plan and Executive Orders on AI, new industry-specific and comprehensive state laws, and enforcement trends, with a focus on how these changes impact the health care industry.